PT  - JOURNAL ARTICLE
AU  - Berrig, Christian
AU  - Andreasen, Viggo
AU  - Nielsen, Bjarke Frost
TI  - Heterogeneity in testing for infectious diseases
AID  - 10.1101/2022.01.11.22269086
DP  - 2022 Jan 01
TA  - medRxiv
PG  - 2022.01.11.22269086
4099  - http://medrxiv.org/content/early/2022/01/12/2022.01.11.22269086.short
4100  - http://medrxiv.org/content/early/2022/01/12/2022.01.11.22269086.full
AB  - Testing strategies have varied widely between nation states during the COVID-19 pandemic, in intensity as well as methodology. Some countries have mainly performed diagnostic testing while others have opted for mass-screening for the presence of SARS-CoV-2 as well. COVID passport solutions have been introduced, in which access to several aspects of public life requires either testing, proof of vaccination or a combination thereof. This creates a coupling between personal activity levels and testing behaviour which, as we show, leverages the heterogeneous behaviours in the population and turns this heterogeneity from a disadvantage to an advantage for epidemic control.Competing Interest StatementThe authors have declared no competing interest.Funding StatementOur research has received funding The Carlsberg Foundation, Grant No. 61114.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data and computational code produced in the present study are available upon reasonable request to the authors.